Novartis Comprehensive Leprosy Care Association Profile
Key Indicators
- Paid Up Capital ₹ 8.00 M
- Company Age 30 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -14.38%
- Profit Growth -163.82%
- Ebitda 100.00%
- Net Worth -100.00%
- Total Assets -36.12%
About Novartis Comprehensive Leprosy Care Association
Novartis Comprehensive Leprosy Care Association (NCLCA) is a Private Not For Profit Company incorporated in India on 31 March 1994 and has a history of 30 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Sports Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Shrivastav and Shilpa Joshi serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U92410MH1994NPL077457
- Company No.
077457
- Company Classification
Private Not For Profit Company
- Incorporation Date
31 Mar 1994
- Date of AGM
25 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Novartis Comprehensive Leprosy Care Association?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Shrivastav  | Director | 17-Sep-2019 | Current |
| Shilpa Joshi | Director | 28-Oct-2022 | Current |
Financial Performance of Novartis Comprehensive Leprosy Care Association.
Novartis Comprehensive Leprosy Care Association, for the financial year ended 2024, experienced significant reduction in revenue, with a 14.38% decrease. The company also saw a substantial fall in profitability, with a 163.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 100%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novartis Comprehensive Leprosy Care Association?
Unlock access to Novartis Comprehensive Leprosy Care Association's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Novartis India LimitedShilpa Joshi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novartis Comprehensive Leprosy Care Association?
Unlock and access historical data on people associated with Novartis Comprehensive Leprosy Care Association, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novartis Comprehensive Leprosy Care Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novartis Comprehensive Leprosy Care Association's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
